Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

More AI & Tech

Gritt exits stealth with $34 million for robots to build solar plants—then, everything else

TechCrunch · 1h ago

Anthropic’s landmark $1.5B copyright settlement is approved

TechCrunch · 11h ago

Trump’s latest AI czar has already resigned

TechCrunch · 13h ago

Google is working on a new AI chip designed to make Gemini more efficient

TechCrunch · 14h ago